Later onset of amyotrophic lateral sclerosis in diabetics and no survival effect of statin use


  • Use of statins did not affect survival in people with amyotrophic lateral sclerosis (ALS); people with diabetes mellitus had a later onset of ALS and no difference in median survival.

Why this matters

    These results support the continued use of statins in people with ALS and provide evidence for researching therapeutic targets for ALS relating to the potentially protective metabolic factors associated with diabetes.